Bio-Rad Laboratories Inc

Healthcare · Medical Devices

377.30$ +0.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Bio-Rad Laboratories Inc (BIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 2,583 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BIO
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	419	427	442	550	726	818	893	1,003	1,090	1,181	1,274	1,461	1,764	1,784	1,927	2,074	2,069	2,133	2,175	2,019	2,068	2,160	2,290	2,312	2,546	2,923	2,802	2,671	2,567	2,583
Cost of Revenue	164	170	182	228	300	356	383	438	480	534	561	670	802	784	836	896	908	954	997	898	930	973	1,066	1,055	1,108	1,284	1,235	1,244	1,188	1,240
Gross Profit	255	257	260	322	426	461	509	565	610	646	713	791	963	1,000	1,091	1,178	1,161	1,178	1,179	1,122	1,138	1,187	1,224	1,257	1,438	1,638	1,567	1,427	1,379	1,344
Research & Development	40	46	41	51	68	77	83	94	108	115	123	141	160	164	172	186	214	211	220	193	206	250	199	203	218	261	257	247	296	257
Selling, General & Administrative	156	165	167	195	248	273	289	325	378	416	439	508	591	601	635	696	683	798	808	762	817	809	835	825	800	880	828	847	814	844
Total Operating Expenses	213	230	229	273	359	349	372	420	487	531	562	649	808	765	807	883	897	1,009	1,029	955	1,023	1,059	1,032	1,027	1,017	1,138	1,085	1,089	1,110	1,078
Operating Income	42	27	31	49	67	112	137	146	109	115	146	135	183	231	284	295	264	169	150	167	53	117	-109	230	421	500	483	338	269	271
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32	32	32	47	64	53	51	61	22	22	23	23	24	23	22	1.6	38	49	49	49
Pre-Tax Income	37	23	34	16	45	65	104	114	97	93	142	121	143	186	220	236	232	112	132	146	42	98	507	2,261	4,918	5,449	-4,704	-850	-2,343	996
Income Tax Expense	9.1	6.4	9.9	4.7	14	21	37	38	31	16	39	27	45	37	33	58	62	35	43	33	13	-17	146	502	1,104	1,195	-1,077	-213	-498	236
Net Income	26	16	24	12	31	44	68	76	68	82	103	93	90	145	185	178	169	78	89	113	28	115	361	1,759	3,814	4,254	-3,628	-637	-1,844	760
EBITDA	57	46	52	76	110	153	180	189	174	176	229	220	272	335	393	410	404	305	304	299	206	270	675	2,459	5,078	5,588	-4,489	-655	-2,142	1,250

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings